Abbott earnings preview: Pharma, medical devices to drive Q4 results
Healthcare giant Abbott Laboratories (ABT) is expected to post upbeat results for the fourth quarter on Wednesday before the bell,...
Health Care
Johnson & Johnson Q4 Earnings: stellar pharma sales help deliver upbeat results
Healthcare giant Johnson & Johnson (JNJ) kicked off pharma earnings for the fourth-quarter as it posts higher-than-expected quarterly results on...
Eli Lilly’s oncology push suffers a blow after sarcoma drug fails study
The ambitious cancer therapy program of Eli Lilly and Company (LLY) suffered a setback Friday after a formulation developed by...
Earnings Preview: Will the talc debacle devour Johnson & Johnson in Q4?
Healthcare giant Johnson & Johnson (JNJ) will kick off pharma earnings for the fourth-quarter as it posts its quarterly and...
Why Ligand Pharma, Viking Therapeutics tumbled yesterday, but is gaining today
Shares of Ligand Pharmaceuticals (LGND) took a beating on Wednesday after a bearish report by Citron Research led by short-seller...
Microsoft-Walgreens deal highlights an emerging trend in healthcare sector
While the healthcare sector is witnessing a dramatic change in the way companies operate, marked by high-profile partnerships, the tech...
UnitedHealth beats estimates on Q4 results
UnitedHealth Group (UNH) surpassed market expectations on both revenue and earnings for the fourth quarter of 2018. Shares were up...
Verona Pharma stock plunges to all time low on disappointing trial
Verona Pharma plc (VRNA) stock plunged to an all-time low of $5.76 on Monday as its lead chronic inflammatory lung...
Aurora gets bigger with Whistler buyout as cannabis boom gains traction
The cannabis market seems to be on the verge of an explosion – with the majority of companies expediting their...
Earnings preview: Strong Q4 results might lift UnitedHealth Group’s stock
UnitedHealth Group (UNH) is scheduled to report fourth-quarter 2018 earnings results on Tuesday, January 15. Analysts expect the company to...
Axsome Therapeutics almost doubles on positive outcome from Alzheimer’s disease trial
Clinical stage biopharmaceutical company Axsome Therapeutics (AXSM) announces positive outcome for ADVANCE-1 trial associated with the treatment of Alzheimer’s disease. Shares of...
In a massive deal, Eli Lilly acquires Loxo Oncology
Eli Lilly and Company (LLY) on Monday announced that it would acquire a small biopharmaceutical startup that develops cancer treatment,...
Flexion Therapeutics plunges after reporting preliminary Q4 financial results
Flexion Therapeutics (Nasdaq: FLXN) reported its preliminary fourth quarter earnings results after the bell today. The biopharmaceutical company’s Q4 revenue is expected...
Johnson & Johnson dips on revenue decline in India
Johnson & Johnson (JNJ) shares fell 1% on Thursday after the company reported a 3% sales dip in India in...
Bristol-Myers Squibb swallows Celgene for $74-bln; Celgene stock surges
Bristol-Myers Squibb (NYSE: BMY) acquired its peer Celgene (NASDAQ: CELG) in a $74-billion cash-and-stock deal. Under the agreement terms, Celgene...
Cambrex Corp. completes acquisition of Avista Pharma solutions
Life sciences company Cambrex Corp. (CBM) Wednesday completed its previously announced acquisition of Avista Pharma Solutions, a biotech firm engaged...
Aphria rejects Green Growth Brands’ $2.1-bln buyout offer
Aphria Inc. (NYSE: APHA and TSX: APHA) turned down the acquisition proposal by Xanthic Biopharma d.b.a. Green Growth Brands (CSE:...
Thailand legalizes medical use of cannabis, opens up a new region for pot stocks
After Uruguay and Canada, Thailand has now amended its drug law to legalize marijuana for medical purposes. However, unlike the...
Budweiser-parent mulls pot-based drinks, inks JV with Tilray
The world’s largest brewery and the parent company of Budweiser, AB InBev (BUD), has given potheads more reasons to cheer...
GSK teams up with Pfizer to announce major changes to business
GlaxoSmithKline plc (GSK) and Pfizer Inc. (PFE) have decided to combine their consumer health businesses in an all-equity transaction that...
Merck strengthens animal health division with $2.4-bln Antelliq buyout
Taking a cue from the growing demand for animal care products, healthcare service providers and pharma companies are enhancing their...